like focu
setup quarter skew neg given recent
out-performance consist phase algorithm
posit offset continu drive acceler
spend debat paramount less visibl
stock expens risk adjust number
strong quarter like acceler revenu
street expect in-lin mse
upsid quarter drove differ result
vs mse underli result in-lin
model gross margin oper margin
respect ahead mse ep
mse ahead street point worth highlight
growth quarter support pt voalt
breath remain immateri becom materi
contributor hh order addit demand
pss flc deliv growth respect surgic
solut ss show lsd declin like evidenc earli
impact capit surgic oem organ
growth driver contribut vs previou
guidanc exhibit full summari result vs mse
manag suspend guidanc strong order book
note volatil environ ahead discuss dynam
setup expect elev quarter market reaction
perceiv insul stori heighten hillrom mid-
play baxter past week
two day post-earn suggest less favor risk-reward
hillrom earn report well anticip signific upsid
medic technolog unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
expect held true order time impli upsid
bed non-invas ventil breath metanab critic patient
monitor impact potenti beyond
understand dynam hillrom expect busi perform in-
line benefit driven demand declin
bed clearest exampl upsid manag
quantifi core medsurg icu bed order vs
segment normal contribut total hillrom revenu estim
thermometri contribut anoth hillrom revenu
segment see slightli less half increment demand seen bed
assum hillrom busi remain
manag expect perform in-lin better posit neg
impact neg impact like surgic solut
primary- expos devic spotvis retinavu
commun annual corpor revenu
respect sens manag assumpt see model
impact exhibit lean conserv quantifi procedur downsid
limit upsid assumpt order book enter
resurg case heighten buy trend assum
exhibit mse impact hillrom segment
revenu base
unaffect posit expos
demand
revenu base see
declin
hh contract mse acut demand breath
increment surgic oem revenu
annual
net model move origin guidanc metric
model revenu reflect organ growth
growth includ breath exclud surgic oem voalt remain
driver organ vs previous model
revenu reflect flat organ growth growth vs
previous revenu sit vs
previous assum contribut margin increment
tax rate bring model ep vs
previou model drop assumpt could prove
conserv keep dollar-revenu project
constant except ss see linger neg impact
discuss seeexhibit model chang
debat clear visibl perspect encapsul
debat acut demand bed acut suppli sustain
part global pandem prepared next year flu season
near-term demand acut capit pressur includ bed pull-forward
pressur beyond current balanc view dont
expect multi-year pandem buy certain data point see hospit
procur insight day takeaway indic pandem prepared
effort underway could drive increas bed capac acceler
replac cycl certain center demand integr solut
earlysens connect second case consid
hillrom demand fleet could look like
height financi crisi hillrom revenu grew
medsurg capit sale remaind hillrom
portfolio grew health system adjust spend
prioriti follow afford act passag hillrom
revenu grew medsurg sale remaind
portfolio grew
hillrom ceo highlight discuss decemb upgrad
overweight medsurg capit sale significantli smaller piec
hillrom revenu base total corpor sale today mind
current model reflect resili growth profil vs period
total cc revenu growth cc revenu growth
model assum neg headwind harder comp
prolong acut demand discuss risk-adjust financi
view still suggest discount valuat current level
continu see favor setup pt hillrom compon
fit phase phase categori posit offset continu
drive near-term upsid bucket capit discretionari devic
suffer interim although visibl next year challeng
valuat ebitda remain attract vs peer hillrom
discount smid devic recent high market
close hillrom remain track retir report metric
phenomenon continu believ shed greater light materi
launch em expans driver may delay impact due
inevit domin spend decis catalyst
increas contribut voalt breath acquisit flc product traction
 invest new em manag alreadi place
continu see impact underappreci year ahead maintain
view hillrom close valuat gap peer adjust price
reflect ev/ ebitda multipl discount
million except ep
product sale servic
good sold
sale
sale
sale
sale
sale
sale
sale
sale
price target reect ev/ebitda multipl ebitda discount
annual growth margin expans
surpass lrp driven revenu upsid
mix cost initi manag
remain focus addit deal shift
wamgr higher
organ growth rate msd come year
compani execut lrp
recognit growth stabil visibl
margin improv drive multipl
hill-rom multipl re-rat
growth move higher volatil
decreas hillrom revenu base
diversi digit new product
launch em penetr drive
hill-rom growth rate durabl
lrp achiev hillrom new
lrp call growth
annual om expans
ep compound-annual-growth-rate see new lrp
achiev given product pipelin
remain robust end market mix
digit improv lift margin
off-set downsid
consensu
view descript risk reward theme
organ growth remain lsd slowdown
capital-expenditure environ hurt pss
pipelin fail materi expect
initi manifest plan
along top-line shortfal
drive limit margin improv
multipl fall lrp fail
pipelin product drive
increment revenu year lrp
grow strong double-digit
emerg marketspenetr em
china india
view explan region hierarchi
research highest favor quintil
plan
initi drive margin higher
pipelin traction slow fail materi
margin leverag prove difcult
materi declin capital-expenditure environ
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
dollar million except per share data
total revenu
less net incom non-controlling interest
net incom sharehold
ollar illion except per share data
front line
